Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 5,745,613 |
|
|||||
| News | - | ||||||
| Day High | 1.24 | Low High |
|||||
| Day Low | 1.04 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| reAlpha Tech Corporation | AIRE | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.28 | -20.14% | 1.11 | 18:59:20 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.14 | 1.04 | 1.24 | 1.09 | 1.39 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 24,062 | 5,745,613 | US$ 1.12 | US$ 6,455,564 | - | 0.5311 - 523.10 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:59:33 | 1 | US$ 1.1097 | USD |
reAlpha Tech Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 48.53M | 44.12M | - | 122k | -1.25M | -0.03 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
reAlpha Tech News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/24/2024 | 10:36 | Business Wire | reAlpha Tech Corp. Launches Claire, Real Estate’s First.. |
| 4/19/2024 | 15:30 | Business Wire | reAlpha Tech Corp. Announces Financial Results for the.. |
| 3/12/2024 | 15:05 | Business Wire | reAlpha Tech Corp. Announces Financial Results for the.. |
| 2/01/2024 | 15:15 | Business Wire | reAlpha Tech Corp. Announces Executive Appointments |
| 12/18/2023 | 06:45 | Business Wire | reAlpha Tech Corp. Enters into Letter of Intent to Acquire.. |
| 12/15/2023 | 15:53 | Business Wire | reAlpha Tech Corp. Announces Second Quarter 2023 Results and.. |
| 12/04/2023 | 06:00 | Business Wire | reAlpha Tech Corp. to Acquire Naamche to Develop.. |
| 11/24/2023 | 10:47 | Business Wire | reAlpha Announces Closing of $8.0 Million Public Offering |
| 11/21/2023 | 08:25 | Business Wire | reAlpha Announces Pricing of $8.0 Million Public Offering |
| 11/01/2023 | 06:30 | Business Wire | reAlpha Announces Commercial Launch of GENA, a Product for.. |
| 10/23/2023 | 05:00 | Business Wire | reAlpha Announces Effectiveness of Registration Statement.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AIRE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.6934 | 1.66 | 0.5311 | 1.29 | 16,949,380 | 0.4166 | 60.08% |
| 1 Month | 1.22 | 1.66 | 0.5311 | 1.28 | 4,629,423 | -0.11 | -9.02% |
| 3 Months | 1.20 | 2.22 | 0.5311 | 1.43 | 2,637,852 | -0.09 | -7.50% |
| 6 Months | 72.00 | 90.21 | 0.5311 | 3.72 | 1,835,945 | -70.89 | -98.46% |
| 1 Year | 23.01 | 523.10 | 0.5311 | 3.77 | 1,793,337 | -21.90 | -95.18% |
| 3 Years | 23.01 | 523.10 | 0.5311 | 3.77 | 1,793,337 | -21.90 | -95.18% |
| 5 Years | 23.01 | 523.10 | 0.5311 | 3.77 | 1,793,337 | -21.90 | -95.18% |
reAlpha Tech Description
| Bio-Techne Corporation is a global life sciences company. The Company is engaged in providing tools and bioactive reagents for the research and clinical diagnostic communities. It operates through two segments: Protein Sciences and Diagnostics and Genomics. Its Protein Sciences segment develops and manufactures biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits. |
